Optimal vitamin D levels in Crohn's disease: A review

Proceedings of the Nutrition Society

Volumn 74, Issue 1, 2015, Pages 56-66

  Raftery, Tara ^a   O'Sullivan, Maria ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

25 hydroxyvitamin D; Crohn's disease; Inflammation; Vitamin D levels

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; VITAMINS;

ADAPTIVE IMMUNITY; COLON CANCER; CROHN DISEASE; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE SEVERITY; EXCRETION; GENETIC VARIABILITY; HUMAN; HYDROXYLATION; IMMUNOPATHOGENESIS; METABOLITE; MUSCLE FUNCTION; NUTRITIONAL STATUS; RELAPSE; REVIEW; SUNLIGHT; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; BLOOD; COMPLICATION; DIETARY SUPPLEMENTS; HUMANS; PHYSIOLOGY;

CROHN DISEASE; DIETARY SUPPLEMENTS; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84921505683     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665114001591     Document Type: Review

References (140)

1. Xavier RJ & Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434.
2. Abraham C & Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361, 2066-2078.
3. Khor B, Gardet A & Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317.
4. Jostins L, Ripke S, Weersma RK et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124.
5. Ananthakrishnan AN (2013) Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep 15, 302.
6. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357, 266-281.
7. Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80, 6 Suppl., 1678S-1688S.
8. Rosen CJ (2011) Clinical practice. Vitamin D insufficiency. N Engl J Med 364, 248-254.
9. Leslie WD, Miller N, Rogala L et al. (2008) Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol 103, 1451-1459.
10. Laakso S, Valta H, Verkasalo M et al. (2012) Impaired bone health in inflammatory bowel disease: a casecontrol study in 80 pediatric patients. Calcif Tissue Int 91, 121-130.
11. Mowat C, Cole A, Windsor A et al. (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60, 571-607.
12. Ananthakrishnan AN, Khalili H, Higuchi LM et al. (2012) Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 142, 482-489.
13. Cantorna MT & Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229, 1136-1142.
14. Cantorna MT, Zhu Y, Froicu M et al. (2004) Vitamin D status, 1,25-Dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80, 6 Suppl., 1717S-1720S.
15. Jørgensen SP, Agnholt J, Glerup H et al. (2010) Clinical trial: vitamin D3 treatment in Crohn's disease -A randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 32, 377-383.
16. Raftery T, O'Morain CA & O'Sullivan M (2012) Vitamin D: new roles and therapeutic potential in inflammatory bowel disease. Curr Drug Metab 13, 1294-1302.
17. Institute of Medicine (2010) Report Brief: Dietary Reference Intakes for Calcium and Vitamin D.
18. Alkhouri RH, Hashmi H, Baker RD et al. (2013) Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 56, 89-92.
19. Blank S, Scanlon KS, Sinks TH et al. (1995). An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-Delivery dairy. Am J Public Health 85, 656-659.
20. Souberbielle JC, Body JJ, Lappe JM et al. (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9, 709-715.
21. Vieth R (1999). Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69, 842-856.
22. Vieth R (2006) Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 136, 1117-1122.
23. Jones G (2008) Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88, 582S-586S.
24. Maalouf J, Nabulsi M, Vieth R et al. (2008) Short-And long-term safety of weekly high-Dose vitamin D3 supplementation in school children. J Clin Endocrinol Metab 93, 2693-2701.
25. Haddock L & Corcino J, Vazques MD (1982) V. 25(OH)D serum levels in the normal Puerto Rican population and in subjects with tropical sprue and parathyroid disease. Puerto Rico Health Sci J 1, 85-91.
26. Yang L, Weaver V, Smith JP et al. (2013) Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol 4, e33.
27. Hanley DA, Cranney A, Jones G et al. (2010) Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 182, E610-E618.
28. Siffledeen JS, Siminoski K, Steinhart H et al. (2003) The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol 17, 473-478.
29. McCarthy D, Duggan P, O'Brien M et al. (2005) Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther 21, 1073-1083.
30. Harries AD, Brown R, Heatley RV et al. (1985) Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 26, 1197-1203.
31. Gilman J, Shanahan F & Cashman KD (2006) Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr 60, 889-896.
32. Driscoll RH, Meredith SC, Sitrin M et al. (1982) Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 83, 1252-1258.
33. de Bruyn JR, van Heeckeren R, Ponsioen CY et al. (2014) Vitamin D deficiency in Crohn's disease and healthy controls: a prospective case-control study in the Netherlands. J Crohns Colitis 8, 1287-1273.
34. Raftery T, Lee C, Cox G et al. (2013) Supplemental vitamin D in quiescent Crohn's disease -effects on quality of life, fatigue and muscle strength: results from a double blind placebo controlled study. Proc Nutr Soc 72, OCE3, E177.
35. Suibhne TN, Cox G, Healy M et al. (2012) Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. J Crohns Colitis 6, 182-188.
36. Vogelsang H, Klamert M, Resch H et al. (1995) Dietary vitamin D intake in patients with Crohn's disease. Wien Klin Wochenschr 107, 578-581.
37. Filippi J, Al-Jaouni R, Wiroth JB et al. (2006) Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis 12, 185-191.
38. Bin CM, Flores C, Alvares-Da-Silva MR et al. (2010) Comparison between handgrip strength, subjective global assessment, anthropometry, and biochemical markers in assessing nutritional status of patients with Crohn's disease in clinical remission. Dig Dis Sci 55, 137-144.
39. Hollander D & Truscott TC (1976) Mechanism and site of small intestinal uptake of vitamin D3 in pharmacological concentrations. Am J Clin Nutr 29, 970-975.
40. Leichtmann GA, Bengoa JM, Bolt MJ et al. (1991) Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr 54, 548-552.
41. Ulitsky A, Ananthakrishnan AN, Naik A et al. (2011) Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 35, 308-316.
42. Hassan V, Hassan S, Seyed-Javad P et al. (2013) Association between serum 25 (OH) vitamin D concentrations and inflammatory bowel diseases (IBDs) activity. Med J Malaysia 68, 34-38.
43. Jørgensen SP, Hvas CL, Agnholt J et al. (2013) Active Crohn's disease is associated with low vitamin D levels. J Crohns Colitis 7, e407-e413.
44. Ham M, Longhi MS, Lahiff C et al. (2014) Vitamin d levels in adults with Crohn's disease are responsive to disease activity and treatment. Inflamm Bowel Dis 20, 856-860.
45. Farraye FA, Nimitphong H, Stucchi A et al. (2011) Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis 17, 2116-2121.
46. Mouli VP & Ananthakrishnan AN (2014) Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 39, 125-136.
47. Wang TJ, Zhang F, Richards JB et al. (2010) Common genetic determinants of vitamin D insufficiency: a genomewide association study. Lancet 376, 180-188.
48. Simpson S, Blizzard L, Otahal P et al. (2011) Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-Analysis. J Neurol Neurosurg Psychiatry 82, 1132-1141.
49. Peyrin-Biroulet L, Oussalah A & Bigard MA (2009) Crohn's disease: the hot hypothesis. Med Hypotheses 73, 94-96.
50. Frolkis A, Dieleman LA, Barkema H et al. (2013) Environment and the inflammatory bowel diseases. Can J Gastroenterol 27, e18-e24.
51. Spehlmann ME, Begun AZ, Burghardt J et al. (2008) Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 14, 968-976.
52. Khalili H, Huang ES, Ananthakrishnan AN et al. (2012) Geographical variation and incidence of inflammatory bowel disease among US women. Gut 61, 1686-1692.
53. Shivananda S, Lennard-Jones J, Logan R et al. (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39, 690-697.
54. Loftus EV & Sandborn WJ (2002) Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31, 1-20.
55. Schultz M & Butt AG (2012) Is the north to south gradient in inflammatory bowel disease a global phenomenon. Expert Rev Gastroenterol Hepatol 6, 445-447.
56. Burisch J, Pedersen N, Cukovic-Cavka S et al. (2013) Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe -An ECCO-EpiCom study. J Crohns Colitis 8, 607-616
57. Pinsk V, Lemberg DA, Grewal K et al. (2007) Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 102, 1077-1083.
58. Sewell JL, Yee HF & Inadomi JM (2010) Hospitalizations are increasing among minority patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 16, 204-207.
59. Limketkai BN, Bayless TM, Brant SRet al. (2014) Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Aliment Pharmacol Ther 40, 508-517.
60. Cantorna MT & Mahon BD (2005). D-hormone and the immune system. J Rheumatol Suppl 76, 11-20.
61. Jäger S, Stange EF & Wehkamp J (2013) Inflammatory bowel disease: an impaired barrier disease. Langenbecks Arch Surg 398, 1-12.
62. Tollin M, Bergman P, Svenberg T et al. (2003) Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24, 523-530.
63. Otte JM, Zdebik AE, Brand S et al. (2009) Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul Pept 156, 104-117.
64. Gombart AF, Borregaard N & Koeffler HP (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-Dihydroxyvitamin D3. FASEB J 19, 1067-1077.
65. Daniel C, Sartory NA, Zahn N et al. (2008) Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324, 23-33.
66. Tang J, Zhou R, Luger D et al. (2009) Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 182, 4624-4632.
67. Jeffery LE, Burke F, Mura M et al. (2009) 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 183, 5458-5467.
68. Cantorna MT (2012) Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch Biochem Biophys 523, 103-106.
69. Froicu M & Cantorna MT (2007) Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 8, 5.
70. Froicu M, Weaver V, Wynn TA et al. (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17, 2386-2392.
71. Cantorna MT, Munsick C, Bemiss C et al. (2000) 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130, 2648-2652.
72. Henderson P, van Limbergen JE et al. (2011) Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease. Inflamm Bowel Dis 17, 382-395.
73. Marchiando AM, Graham WV & Turner JR (2010) Epithelial barriers in homeostasis and disease. Annu Rev Pathol 5, 119-144.
74. Cantorna MT, McDaniel K, Bora S et al. (2014) Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med (Maywood) 239, 1524-1530.
75. D'Incá R, Di Leo V, Corrao G et al. (1999) Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 94, 2956-2960.
76. Wyatt J, Vogelsang H, Hübl W et al. (1993) Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341, 1437-1439.
77. Kong J, Zhang Z, Musch MW et al. (2008) Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294, G208-G216.
78. Ooi JH, Li Y, Rogers CJ et al. (2013) Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr 143, 1679-1686.
79. Zhang Y, Leung DY, Richers BN et al. (2012) Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188, 2127-2135.
80. HewisonM (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 39, 365-379; table of contents.
81. El-Matary W, Sikora S & Spady D (2011) Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci 56, 825-829.
82. Joseph AJ, George B, Pulimood AB et al. (2009) 25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity. Indian J Med Res 130, 133-137.
83. Ananthakrishnan AN, Cagan A, Gainer VS et al. (2013) Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis 19, 1921-1927.
84. Boyd CA & Limdi JK (2013) Vitamin D deficiency and disease outcomes in South Asian patients with IBD. Dig Dis Sci 58, 2124-2125.
85. Miheller P, Muzes G, Hritz I et al. (2009) Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis 15, 1656-1662.
86. Raftery T, Martineau A, Greiller C et al. (2013) Does vitamin D supplementation impact plasma cathelicidin, human beta defensin 2 and intestinal permeability in stable Crohn's disease -Results from a randomised, double blind placebo controlled study. Proc Nutr Soc 72, OCE3, E176.
87. Schneider SM, Al-Jaouni R, Filippi J et al. (2008) Sarcopenia is prevalent in patients with Crohn's disease in clinical remission. Inflamm Bowel Dis 14, 1562-1568.
88. Wiroth JB, Filippi J, Schneider SM et al. (2005) Muscle performance in patients with Crohn's disease in clinical remission. Inflamm Bowel Dis 11, 296-303.
89. Geerling BJ, Badart-Smook A, Stockbrügger RW et al. (1998) Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 67, 919-926.
90. van Langenberg DR, Della Gatta P, Warmington SA et al. (2014) Objectively measured muscle fatigue in Crohn's disease: correlation with self-reported fatigue and associated factors for clinical application. J Crohns Colitis 8, 137-146.
91. Jelsness-Jorgensen LP, Bernklev T, Henriksen M et al. (2012) Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease. World J Gastroenterol 18, 445-452.
92. Casati J, Toner BB, de Rooy EC, Drossman DA et al. (2000) Concerns of patients with inflammatory bowel disease: a review of emerging themes. Dig Dis Sci 45, 26-31.
93. Drossman DA, Patrick DL, Mitchell CM et al. (1989) Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 34, 1379-1386.
94. Maunder RG, de Rooy EC, Toner BB et al. (1997) Health-related concerns of people who receive psychological support for inflammatory bowel disease. Can J Gastroenterol 11, 681-685.
95. Minderhoud IM, Oldenburg B, van Dam PS et al. (2003) High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 98, 1088-1093.
96. Reimund JM, Wittersheim C, Dumont S et al. (1996) Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 16, 144-150.
97. Cominelli F (2004) Cytokine-based therapies for Crohn's disease-new paradigms. N Engl J Med 351, 2045-2048.
98. Visser M, Pahor M, Taaffe DR et al. (2002) Relationship of interleukin-6 and tumor necrosis factor-Alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57, M326-M332.
99. Schaap LA, Pluijm SM, Deeg DJ et al. (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119, e9-e17.
100. Al-Shoha A, Qiu S, Palnitkar S et al. (2009) Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity. Endocr Pract 15, 528-533.
101. Schott GD & Wills MR (1976) Muscle weakness in osteomalacia. Lancet 1, 626-629.
102. Mawer EB, Backhouse J, Holman CA et al. (1972). The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 43, 413-431.
103. Boillon R, Gielen E & Vanderschueren D (2014) Vitamin D receptor and vitamin D action in muscle. Endocrinology 155, 3210-3213.
104. Pfeifer M, Begerow B, Minne HW et al. (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in communitydwelling older individuals. Osteoporos Int 20, 315-322.
105. van Langenberg DR, Gatta PD, Hill B et al. (2013) Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease. J Crohns Colitis 8, 626-634.
106. Salacinski AJ, Regueiro MD, Broeder CE et al. (2013) Decreased neuromuscular function in Crohn's disease patients is not associated with low serum vitamin D levels. Dig Dis Sci 58, 526-533.
107. Wacker M & Holick MF (2013) Vitamin D -effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 5, 111-148.
108. Feskanich D, Ma J, Fuchs CS et al. (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13, 1502-1508.
109. Giovannucci E (2007) Strengths and limitations of current epidemiologic studies: vitamin D as a modifier of colon and prostate cancer risk. Nutr Rev 65,Pt 2, S77-S79.
110. Giovannucci E (2009) Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 19, 84-88.
111. Giovannucci E, Liu Y, Rimm EB et al. (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98, 451-459.
112. Lappe JM, Travers-Gustafson D, Davies KM et al. (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85, 1586-1591.
113. Cannell JJ & Hollis BW (2008) Use of vitamin D in clinical practice. Altern Med Rev 13, 6-20.
114. Heaney RP, Davies KM, Chen TC et al. (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77, 204-210.
115. Heaney RP, Horst RL, Cullen DM et al. (2009) Vitamin D3 distribution and status in the body. J Am Coll Nutr 28, 252-256.
116. Grant WB & Holick MF (2005) Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10, 94-111.
117. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135, 317-322.
118. Bischoff-Ferrari HA, Willett WC, Orav EJ et al. (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367, 40-49.
119. Hall LM, Kimlin MG, Aronov PA et al. (2010) Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr 140, 542-550.
120. Vieth R (2006) What is the optimal vitamin D status for health Prog Biophys Mol Biol 92, 26-32.
121. Whiting SJ & Calvo MS (2010) Correcting poor vitamin D status: do older adults need higher repletion doses of vitamin D3 than younger adults Mol Nutr Food Res 54, 1077-1084.
122. Garrett-Mayer E, Wagner CL, Hollis BW et al. (2012) Vitamin D3 supplementation (4000 IU/d for 1 y) eliminates differences in circulating 25-hydroxyvitamin D between African American and white men. Am J Clin Nutr 96, 332-336.
123. Holick MF (2012) Vitamin D: extraskeletal health. Rheum Dis Clin North Am 38, 141-160.
124. Barger-Lux MJ & Heaney RP (2002) Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 87, 4952-4956.
125. Azizi E, Pavlotsky F, Kudish A et al. (2012) Serum levels of 25-hydroxy-vitamin D3 among sun-protected outdoor workers in Israel. Photochem Photobiol 88, 1507-1512.
126. Luxwolda MF, Kuipers RS, Kema IP et al. (2012) Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr 108, 1557-1561.
127. Hathcock JN, Shao A, Vieth R et al. (2007) Risk assessment for vitamin D. Am J Clin Nutr 85, 6-18.
128. Tajika M, Matsuura A, Nakamura T et al. (2004) Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol 39, 527-533.
129. Jahnsen J, Falch JA, Mowinckel P et al. (2002) Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 37, 192-199.
130. Wingate KE, Jacobson K, Issenman R et al. (2014) 25-Hydroxyvitamin D concentrations in children with Crohn's disease supplemented with either 2000 or 400 IU daily for 6 months: a randomized controlled study. J Pediatr 164, 860-865.
131. Sentongo TA, Semaeo EJ, Stettler N et al. (2002) Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 76, 1077-1081.
132. Pappa HM, Gordon CM, Saslowsky TM et al. (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118, 1950-1961.
133. Vagianos K, Bector S, McConnell J et al. (2007) Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 31, 311-319.
134. Fu YT, Chatur N, Cheong-Lee C et al. (2012) Hypovitaminosis D in adults with inflammatory bowel disease: potential role of ethnicity. Dig Dis Sci 57, 2144-2148.
135. Ananthakrishnan AN, Cheng SC, Cai T et al. (2013) Association between reduced plasma 25-hydroxy vitamin Dand increased risk of cancer in patientswith inflammatory bowel diseases. Clin Gastroenterol Hepatol 12, 821-827.
136. Garg M, Rosella O, Lubel JS et al. (2013) Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis 19, 2634-2643.
137. Grunbaum A, Holcroft C, Heilpern D et al. (2013) Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families. Nutr J 12, 145.
138. Abraham BP, Prasad P & Malaty HM (2014) Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Dig Dis Sci. 59, 1878-1884.
139. Dumitrescu G, Mihai C, Dranga M et al. (2014) Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. World J Gastroenterol 20, 2392-2396.
140. Ananthakrishnan AN, Cheng SC, Cai T et al. (2014) Association between reduced plasma 25-hydroxy vitamin d and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 12, 821-827.